A phase 1 study to evaluate the safety and tolerability of MEDI4736, an anti-PD-L1 antibody, in combination with tremelimumab in patients with advanced solid tumors Meeting Abstract
| Authors: | Callahan, M. K.; Ott, P. A.; Odunsi, K.; Bertolini, S. V.; Pan, L. S.; Venhaus, R. R.; Karakunnel, J. J.; Hodi, F. S.; Wolchok, J. D. |
| Abstract Title: | A phase 1 study to evaluate the safety and tolerability of MEDI4736, an anti-PD-L1 antibody, in combination with tremelimumab in patients with advanced solid tumors |
| Meeting Title: | 50th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 32 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2014 May 30-Jun 3 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2014-05-20 |
| Language: | English |
| ACCESSION: | WOS:000358613202058 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2014.32.15_suppl.tps3120 |
| Notes: | Meeting Abstract: TPS3120^ -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work